![David O' Neill](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David O' Neill
Directeur/Bestuurslid bij Triphase Accelerator Corp.
Oorsprong van het eerstegraads netwerk van David O' Neill
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Fight Against Cancer Innovation Trust
![]() Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust is a venture capital firm founded in 2014. The firm is headquartered in Toronto, Canada.
11
| Private Company | Investment Managers | 11 |
Triphase Accelerator Corp.
![]() Triphase Accelerator Corp. BiotechnologyHealth Technology Triphase Accelerator Corp. develops oncology drug therapeutics. It engages in accelerating oncology products from pre-investigational new drug (pre-IND) to Phase I/Phase II POC. The firm?s product includes Marizomib which is used in cancer treatment. The company is headquartered in Toronto, Canada.
4
| Holding Company | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David O' Neill via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Ontario Institute for Cancer Research
![]() Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | President Director/Board Member Director/Board Member | |
Toronto Innovation Acceleration Partners
![]() Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member Chief Executive Officer Chief Executive Officer | |
Ottawa Life Sciences Council | Chairman President | ||
University of Ottawa | College/University | Graduate Degree Doctorate Degree | |
The University of Waterloo | College/University | Graduate Degree | |
Capital Angel Network
![]() Capital Angel Network Miscellaneous Commercial ServicesCommercial Services Capital Angel Network operates as an association of individual angel investors and venture capital firms. The firm connects entrepreneurs with angels, investments are made individually and also provides members with opportunities to increase their exposure to quality pre-screened companies seeking capital and gives the Angel investors the opportunity to expand their network of like-minded investors. The company is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Notch Therapeutics, Inc.
![]() Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | Pharmaceuticals: Other | Chairman | |
Fibrocor Therapeutics LP
![]() Fibrocor Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Fibrocor Therapeutics LP is a privately held Canadian drug discovery company that is pioneering the use of tissue-specific therapeutics in the field of precision medicine, particularly in fibrosis. The company is based in Toronto, Canada. The company aims to improve the lives of patients by delivering transformative treatments that tackle the root causes of fibrosis, leading to better outcomes and enhanced quality of life. Fibrocor leverages its extensive expertise and one of the largest patient-derived clinically annotated biorepositories of fibrotic tissue to refine and validate therapeutic candidates, ensuring they meet the highest standards of efficacy and safety. | Miscellaneous Commercial Services | Chairman | |
International Genetic Science Partnership | Corporate Officer/Principal | ||
SCOPUS BIOPHARMA INC. | Pharmaceuticals: Other | Director/Board Member | |
Bedside Clinical Systems, Inc.
![]() Bedside Clinical Systems, Inc. Packaged SoftwareTechnology Services Bedside Clinical Systems, Inc. develops Responses to Illness Severity Quantification (RISQ) framework severity of illness clinical decision support for frontline healthcare professionals, hospital administrators and quality managers. It provides BedsidePEWS, that uses the RISQ framework to empower frontline clinicians who care for hospitalized children. The company was founded by Christopher Parshuram in March 2011 and is headquartered in Toronto, Canada. | Packaged Software | Director/Board Member | |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
Epitope Capital Corp. | Chief Executive Officer | ||
QD Solar, Inc.
![]() QD Solar, Inc. SemiconductorsElectronic Technology QD Solar, Inc. develops photovoltaic cells using colloidal quantum dot technology in Canada. Its quantum dot technology combines silicon solar cells with infrared solar cells in a hybrid architecture to harvest more of the solar spectrum than silicon alone. The company was founded by Sjoerd Hoogland and Edward Hartley Sargent in 2014 and is headquartered in Toronto, Canada. | Semiconductors | Director/Board Member | |
Accel-Rx
![]() Accel-Rx Financial ConglomeratesFinance Accel-Rx provides seed and start-up investment services to the new health sciences companies. It engages in leveraging investment support to the research and commercialization centers such as the existing health-related Centers of Excellence for Commercialization and Research (CECRs). The company was founded by Natalie Dakers in 2014 and is headquartered in Vancouver, Canada. | Financial Conglomerates | Director/Board Member | |
Encycle Therapeutics, Inc.
![]() Encycle Therapeutics, Inc. BiotechnologyHealth Technology Encycle Therapeutics, Inc. provides biotechnology services. It offers rapid synthesis of drug-like macrocycles or membrane-permeable nacellins which have enormous potential to target intracellular protein-protein interactions. The company was founded by Andrei Yudin is headquartered in Toronto, Canada. | Biotechnology | Chairman | |
Cell Cure Neurosciences Ltd.
![]() Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | Biotechnology | Director/Board Member | |
Clinical Trials Ontario
![]() Clinical Trials Ontario Miscellaneous Commercial ServicesCommercial Services Clinical Trials Ontario operates as a research and development company for various diseases. The company was founded in 2012 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Chairman | |
Life Sciences Ontario | Director/Board Member | ||
Terheuer Ltd. | Director/Board Member | ||
Nucleus GC, Inc. | Founder | ||
MEDWORXX SOLUTIONS INC. | Packaged Software | Director/Board Member | |
Ontario Bioscience Industry Organization
![]() Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Chief Executive Officer | |
York University | College/University | Undergraduate Degree | |
Stanford University | College/University | Doctorate Degree | |
SHI Consulting, Inc.
![]() SHI Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services SHI Consulting, Inc. operates as a business management consultancy. The company was founded by Borys Chabursky and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Manitoba | College/University | Undergraduate Degree | |
University of Alberta | College/University | Doctorate Degree | |
University of New Brunswick | College/University | Undergraduate Degree | |
Queen's University | College/University | Undergraduate Degree | |
Turnstone Biologics, Inc.
![]() Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Biotechnology | Corporate Officer/Principal | |
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Private Equity Investor | |
MERCK KGAA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Toronto | College/University | Doctorate Degree | |
IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
The Schulich School of Business | College/University | Masters Business Admin | |
Western University | College/University | Undergraduate Degree | |
Scientus Pharma, Inc.
![]() Scientus Pharma, Inc. Agricultural Commodities/MillingProcess Industries Scientus Pharma, Inc. provides biopharmaceutical products extracted from the cannabis plant. The private company is based in Whitby, Canada. | Agricultural Commodities/Milling | Chief Executive Officer | |
GeneTether, Inc.
![]() GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Miscellaneous Commercial Services | Chief Executive Officer | |
HydRx Farms Ltd.
![]() HydRx Farms Ltd. Agricultural Commodities/MillingProcess Industries HydRx Farms Ltd. operates as a biopharmaceutical licensed dealer with a focus on developing and commercializing pharmaceutical-grade cannabinoid derivative products. The firm engages in the producing and processing of medical marihuana and other controlled substances under the Health Canada Medical Marihuana Purpose Regulation (MMPR) program and other NCR regulations. The company was founded by Thomas Jefferd and Trevor Folk in 2014 and is headquartered in Whitby, Canada. | Agricultural Commodities/Milling | Chief Executive Officer | |
Armour Therapeutics, Inc.
![]() Armour Therapeutics, Inc. Medical/Nursing ServicesHealth Services Armour Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development of a new class of anti-hormone therapeutics for the treatment of reproductive tissue-based cancers. The company was founded by Josh Silvertown in 2009 and is headquartered in Toronto, Canada. | Medical/Nursing Services | Chairman | |
Dynamic Memory Medical Technologies Ltd. | Director/Board Member |
Statistieken
Internationaal
Canada | 35 |
Israël | 9 |
Verenigde Staten | 6 |
Verenigd Koninkrijk | 2 |
Duitsland | 2 |
Sectoraal
Health Technology | 14 |
Consumer Services | 12 |
Commercial Services | 8 |
Health Services | 5 |
Process Industries | 4 |
Operationeel
Director/Board Member | 52 |
Chairman | 22 |
Chief Executive Officer | 14 |
Corporate Officer/Principal | 13 |
President | 12 |
Sterkste connecties
- Beurs
- Insiders
- David O' Neill
- Bedrijfsconnecties